Assembly of antigen-presenting complexes between class I MHC molecules and peptide requires formation of a complex between the 'ABC' peptide transporter, TAP, and newly synthesized class I molecules. Recent studies have provided new insights into the role of ATP in peptide binding, transport and release.
The antigen-recognising part of the immune system has two main arms: the B lymphocytes which produce antibodies, and two types of T lymphocyte, the 'helper' T cells which promote the maturation of antibody-producing B cells and the 'cytotoxic' T cells which kill virusinfected and tumour cells. The most important function of the immune system -distinguishing between healthy and abnormal tissue -fall primarily to T cells. Cytotoxic T cells perform this task via their interaction with class I molecules of the major histocompatibility complex (MHC), which bind antigenic peptides within the cell and present them at the cell surface. The assembly of class I MHC molecules is a complex affair, dependent on protein degradation in the cytosol and transport of the resulting peptides into the lumen of the endoplasmic reticulum (ER). The import of peptides into the ER is mediated by the transporter associated with antigen processing (TAP), a member of the ATP-binding cassette (ABC) family of transporters. Recent studies [1, 2] have provided new insight into the behaviour of TAP during peptide-class I molecule assembly, particularly the role ATP plays in regulating transitions between different conformational states of TAP.
The ABC transporter family ABC transporters form the largest and most diverse family of membrane-spanning transport proteins [3] . This family is of ancient evolutionary origin -members have been identified throughout the animal and plant kingdoms and in bacteria. ABC transporters span the external membranes of prokaryotic cells and both external and internal membranes of eukaryotes. Despite billions of years of divergence, ABC transporters can readily be recognised by their distinctive modular structure, with two large, multi-membrane-spanning domains and two smaller, Lshaped nucleotide-binding domains (Figure 1 ). The membrane-spanning domains contain sequences which impart substrate specificity, whereas the nucleotidebinding domains power transport by hydrolysing ATP [4, 5] .
Despite their shared architecture, ABC transporters are responsible for the movement across membranes of a diverse set of substrates, including proteins, sugars, fattyacids, vitamins, pigments and ions. Examples of wellknown ABC proteins are the bacterial histidine and maltose transporters, the yeast a mating factor transporter, the P-glycoprotein associated with multidrug resistance and the cystic fibrosis transmembrane conductance regulator (CFTR). Many mammalian ABC transporters have been discovered in the last decade, including the hepatic canalicular multispecific organic anion transporter, the pancreatic sulfonylurea receptor, and the cholesterol efflux regulatory protein. Like the CFTR, many of the newly identified mammalian transporters are associated with genetic disease and are the subject of intense scientific and clinical interest. We focus here on the 'transporter associated with antigen processing' -TAP -an ABC transporter with a unique and central role in the immune system.
TAP and peptide transport
Cytotoxic T cells are critical to the normal functioning of our immune system as they are responsible for killing both virus-infected and tumourigenic cells. As mentioned above, cytotoxic T cells perform this vital function by sampling the protein content of the cell, in the form of small peptides bound to MHC class I molecules. MHC class I molecules -unlike the class II molecules The synthesis and assembly of class I molecules is a complex process [6] . The class I polypeptides are co-translationally inserted into the ER by the usual (Sec61) translocation machinery. They cannot fold or leave the ER, however, until the class I molecule is stabilized by a short peptide which binds to a pocket formed by polymorphic residues in the amino-terminal half of the class I molecule. Most class I-binding peptides are generated in the cytosol by the normal degradative activity of proteasomes, and these peptides must then be delivered to nascent class I molecules in the ER. This crucial transport step is performed by the TAP transporter.
TAP is currently the only known ABC transporter in the ER membrane. Unusually for a mammalian transporter, TAP is a heterodimer with two distinct subunits, TAP1 and TAP2. The peptide-binding site of TAP is formed by residues on the membrane-spanning domains of both TAP1 and TAP2 [7] . This binding site is promiscuous and can accommodate a wide variety of peptides, ranging in length from 8-16 residues. There is, however, some peptide selectivity exerted by the amino-terminal residues, particularly at position 2, and by the carboxyl terminal residues [8] .
TAP and the class I loading complex
The view that TAP plays a pivotal role in class I assembly derives from the observation that it not only delivers peptide to the ER, but also forms the nucleus of a large 'loading complex' critical for class I maturation ( Figure 2 ). This cluster of proteins includes unfolded class I molecules, the general molecular chaperones of the ER, Dispatch R821 The TAP-class I loading complex. Newly synthesised class I heavy chains combine with β2-microglobulin to form an incompletely folded class I molecule. These immature class I molecules bind to TAP in association with tapasin and the ER chaperones calreticulin and Erp57. TAP delivers proteasome generated peptides from the cytosol to the waiting class I molecules. When a class I molecule binds a suitable peptide, it completes the folding process and is released from the loading complex.
calreticulin and Erp57, and the tapasin protein, which appears to be dedicated to class I assembly [9] . The class I loading complex is a dynamic assembly in which unfolded class I molecules and associated chaperones are delivered to TAP, become transiently associated, and are then released again as the class I molecules bind peptide and complete the folding process.
Recent measurements of the lateral diffusion of class I molecules in the ER membrane have shown that class I molecules associated with the TAP complex diffuse much more slowly than free class I molecules [10] , suggesting that the TAP complex is an extremely large structure [10] . Although a minimal estimate of loading complex stoichiometry has been published [11] , precise determination of its composition and stoichiometry are complicated by the fluid nature of the loading complex.
ATP: energy source and allosteric regulator of TAP
Although it has been almost ten years since TAP was identified as the class I peptide transporter, little progress has been made in characterising the actual mechanism of peptide transport and the steps leading to class I release. This is beginning to change, however, as illustrated by two recent studies [1, 2] which have provided new insights into the role of ATP in TAP function. Van Endert [1] found that nucleotides and peptide play a critical role in stabilizing the TAP heterodimer. TAP is unstable at physiological temperate (37°C), but it can be stabilized by both peptide and nucleotides. This effect appears to be mediated through the TAP1 polypeptide.
As recently reported in Current Biology, Knittler et al. [2] investigated the effect of ATP binding on TAP function by generating TAP molecules -derived from the rat version of the proteins -which could not bind ATP as a result of mutations in the 'Walker A motif' of the nucleotide binding domains. When expressed in the TAP-negative human cell line T2, the mutant TAP molecules did not promote class I maturation. Unable to bind ATP, the mutant proteins have no source of energy to fuel peptide transport. The mutant TAPs had a shorter half-life than wild-type molecules, but were still able to associate with other proteins to form apparently normal loading complexes.
As might have been predicted, Knittler et al. [2] found that the class I molecules were stably associated with the mutant TAP complex, rather than transiently associated as they are with the wild-type TAP complex. Stabilisation of the TAP-class I interaction has been observed in other settings where peptide transport has been blocked or disrupted, such as by viral products, proteasome inhibitors or when there are allele-specific incompatibilities between components of the loading complex [12] . The nature of the stabilisation observed by Knittler et al. [2] was fundamentally different, however, as the class I molecules could not be dissociated from the mutant TAP complex in vitro by conventional methods. Class I molecules that co-precipitate with wild-type TAP molecules can be dissociated by addition of an allele-specific class I-binding peptide to the detergent lysate. The fact that even 100 µM concentrations of peptide could not release class I molecules from the mutant TAP complex suggested that such release might be dependent on either nucleotide binding or nucleotide hydrolysis. As the release of folded class I molecules occurs secondary to peptide transport, the requirement for nucleotide in this downstream step had gone overlooked.
This unexpected result prompted a re-examination of the role of ATP in the action of wild-type TAP molecules. The depletion of ATP from detergent lysates, using the enzyme apyrase, prevented class I release from wild-type TAP in vitro; the release could be restored by addition of ATP, ADP or a non-hydrolyzable ATP analogue. The release of class I molecules from the TAP complex thus requires the presence of di-or tri-phosphates, but is not dependent on hydrolysis. This suggests that nucleotides have a role in both regulating and powering the transport cycle. In experiments with TAP mutants that bind but do not hydrolyse ATP, we have also found that nucleotides play a critical role in both the binding of peptide to TAP and the subsequent release of class I molecules (our unpublished data).
Another group, however, has found that nucleotides do not appear to play a role in the dissociation of HLA-A2 from TAP (S.J. Powis, personal communication). The HLA-A2 class I molecule binds signal-sequence-derived peptides and associates with TAP, but it is not dependent on TAP for peptide delivery. Powis and colleagues found that, in transfected TAP-negative cells that produce either a single TAP polypeptide or a truncated form of TAP lacking the nucleotide-binding domain, release of HLA-A2 is independent of nucleotides. The systems used by the two groups are not, however, directly comparable. Single TAP polypeptides may not undergo the same conformational changes as the complete TAP1-TAP2 heterodimer. Furthermore, the absence of a nucleotide binding domain may release class I from the usual control mechanisms.
The most surprising observation made by Knittler et al. [2] was that peptide binding was disrupted in the mutant TAP molecules. Previous studies on wild-type TAPs -again using apyrase for ATP depletion -showed that, while peptide translocation requires the energy of ATP hydrolysis, peptide binding to TAP is ATP independent [13, 14] . The inability of the mutant TAP molecules to bind peptide seems to directly contradict these findings. As Knittler et al. [2] did not determine whether ATP depletion prevented peptide binding in their wild-type cells, this issue remains unresolved. But as discussed below, a role for nucleotides as allosteric regulators of substrate binding is not without precedent among ABC transporters. A possible explanation for these seemingly contradictory findings is that wild-type TAP molecules have ATP-binding sites that apyrase cannot access, so that -unlike the mutant molecules that lack a nucleotide-binding domain altogetherwild-type TAP molecules still bind some nucleotide even after apparent nucleotide depletion [15, 16] (Figure 3 ).
Multiple conformations of ABC transporters
Taken together, these results suggest that ATP is required, not only for powering peptide transport, but also for regulating transitions between different conformational states of the TAP transporter. Knittler et al. [2] speculate that the rate of nucleotide hydrolysis and exchange could play an important role in coordinating the transport of peptide with the folding and release of class I molecules. The conversion of ATP to ADP, and its subsequent exchange for ATP, could trigger a series of conformational changes which propagate into the membrane-spanning domains. Such a cycle of regular, repeated conformational transitions might help to synchronise the arrival of peptide with the subsequentand still uncharacterised -events in which peptide is transferred to nascent class I molecules and the disulphide bonds characteristic of a mature class I molecule are formed.
What other evidence might support such a model? Nucleotide-driven conformational changes have long been presumed to be a feature of ABC transporter function [17] . The best and most detailed evidence for such conformational transitions comes from studies of Pglycoprotein and CFTR [17, 18] . The biochemical robustness of P-glycoprotein, in particular, has made it possible to study its conformation using a wide variety of approaches, such as spectroscopy, deuterium-hydrogen exchange, protease sensitivity, chemical cross-linking and reactivity with a conformation-sensitive antibody. The results obtained using these different methods all support the view that P-glycoprotein undergoes large conformational changes as it binds ATP or ADP. It is also clear that P-glycoprotein substrates, such as vinblastine or verapamil, also trigger conformational changes, and that these are distinct from those induced by nucleotide binding. Similar observations have been made with CFTR: the frequency and duration of CFTR chloride channel opening was seen to be regulated by its nucleotidebinding domains, which furthermore appear functionally distinct, each responsible for different properties of the wild-type channel [19, 20] .
For both P-glycoprotein and CFTR, it has been possible to build models which incorporate ATP-binding and hydrolysis in discrete steps of the drug transport or chloride conduction cycle [18] . A central feature of both models is the strong interaction observed between the two nucleotide-binding domains. ATP hydrolysis at one nucleotide-binding domain promotes nucleotide exchange on the other. In the initial state, the transporter is thought to have ATP bound to the amino-terminal nucleotide-binding domain, NBD1, and ADP bound to the carboxy-terminal nucleotide-binding domain, NBD2. Nucleotide hydrolysis on NBD1 allows ADP to be released from NBD2, which can then bind ATP and undergo a round of ATP hydrolysis. This cooperative interaction between the two nucleotide-binding domains is thought to drive the ABC transporter through an ordered set of conformational changes in which the substrate is delivered across the lipid bilayer and the transporter returned to its initial state, ready to begin another transport cycle. 
